Mutated KEAP1/NRF2 genes activate downstream oxidation reaction components (AREs), detoxification, and cell metabolism-related gene transcription levels, thereby changing cell oxidative stress levels to promote the occurrence of lung cancer. This evidence concerns the gene KEAP1 and lung carcinoma.